Access to quality medicines and healthcare
Access to quality medicines is a major challenge facing public health policies in Africa where falsified medicines are a widespread danger.
Some of these falsified medicines contain no active ingredients, while in others the ingredients are present in inadequate doses, and still others contain highly toxic substances.
These fake medications harm patients due to their uselessness in treating serious diseases and contribute to increasing treatment-resistant strains of infectious diseases. Worse, in far too many cases they cause death.
Although purchasing medications in developing countries always represents a heavy financial burden for patients, such wasteful expenditures have dramatic economic consequences for families.
The distribution of harmful or inactive medicines that escape all control constitutes a danger to the health and safety of populations, a moral scandal and an enormous challenge for actors involved in development.
|
|
|
The Fondation Chirac’s projects
Extension of the Benin National Laboratory of Quality Control of medicines
To attain regional scope and consolidate the policy of access to quality medicines in West Africa, the overarching public health and safety challenge, the national laboratory of quality control of medicines Benin must obtain certification from the World Health Organization. This requires the extension of its facilities as well as the enhancement of its technical and human resources, which will strengthen its control and training missions on the national and regional scale.
> Read more
The Cotonou Declaration, October 12, 2009
President Jacques Chirac, in the presence of the Honorable Thomas Boni Yayi, President of Benin, and the Honorable Blaise Compaoré, President of Burkina Faso, and several other heads of state and directors of international organizations, called political leaders to fight against the traffic of falsified medicines.
> Read more
Implementing national committees against false medicines
The signing of an international convention, a judicial framework in which to act, must be supported by a demonstration that at the national level, the necessary conditions for effective action have been united. The Fondation encourages those countries that have signed the Cotonou Declaration to create organizational committees that will bring together administrations and non-governmental entities.
> Read more
Managing Director and Scientific Committee
Marc Gentilini is the Managing Director for access to health and quality medication. He is assisted by Pierre Catalan.
> Read more
News and events
President Jacques Chirac joins the UNAIDS High Level Commission on HIV Prevention
As UNAIDS Executive Director Michel Sidibé asked him, President Jacques Chirac joins the UNAIDS High Level Commission on HIV Prevention. > Read more
Adapting the MDGs to new issues, by Philippe Brongniart
On May 19, 2010, the Ministry of Foreign and European Affairs brought together French leaders in the field of cooperation and development to discuss the Millennium Development Goals (MDGs). > Read more
Jacques Chirac addresses the World Customs Organization Council, June 24, 2010
As part of the international mobilization campaign against the traffic of falsified medicines, President Jacques Chirac addresses the World Customs Organization (WCO). > Read more
